Ogeda
discovers, develops and commercializes small-molecule drugs for the treatment of endocrine, inflammatory and women's health disorders... Read moreOgeda
discovers, develops and commercializes small-molecule drugs for the treatment of endocrine, inflammatory and women's health disorders... Read more
General Manager
Rui Patrao
News
Oct 29, 2018
BioPortfolio
Ogeda: Ogeda SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11102018 Prices from USD $250
Jul 28, 2018
BioPortfolio
Ogeda: Ogeda SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Apr 09, 2018
BioPortfolio
Ogeda: Ogeda SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Oct 18, 2017
BioPortfolio
Ogeda: Ogeda SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24082017 Prices from USD $250
May 19, 2017
BioPortfolio
Ogeda: Astellas completes 800 million euro biotech acquisition
Apr 04, 2017
BioPortfolio
Ogeda: Astellas to Acquire Ogeda Expanding its SmallMolecule Drug Pipeline
Apr 03, 2017
BioPortfolio
Ogeda: Ogeda SA Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
Apr 02, 2017
PharmaLive
Ogeda: Astellas Takes Out Belgium Biotech in Deal Worth $853 Million
Apr 01, 2017
Reuters
Ogeda: BRIEF-Astellas Pharma to acquire Ogeda SA
Jan 05, 2017
Drug Development Technology
Ogeda:
Ogeda reports positive top-line data from Phase IIa trial of fezolinetant to treat menopausal hot flashes
Ogeda Competitors
1
2
3
4
5
6
7
8
9
10